RNS Number : 0064V
Legal & General UCITS ETF PLC
03 August 2020
| Funds |
Date |
ISIN code |
Shares in Issue |
Currency |
Net Asset Value |
NAV/per share Base |
| L&G US Equity UCITS ETF |
03/08/2020 |
IE00BFXR5Q31 |
12547267 |
USD |
156287464.18 |
12.456 |
| L&G UK Equity UCITS ETF |
03/08/2020 |
IE00BFXR5R48 |
1200000 |
GBP |
10695203.72 |
8.913 |
| L&G Global Equity UCITS ETF |
03/08/2020 |
IE00BFXR5S54 |
2900000 |
USD |
34376646.13 |
11.854 |
| L&G Japan Equity UCITS ETF |
03/08/2020 |
IE00BFXR5T61 |
11185000 |
USD |
116035460.13 |
10.374 |
| L&G Europe ex UK Equity UCITS ETF |
03/08/2020 |
IE00BFXR5V83 |
9360988 |
EUR |
101322886.96 |
10.824 |
| L&G Asia Pacific ex Japan Equity UCITS ETF |
03/08/2020 |
IE00BFXR5W90 |
5181427 |
USD |
54302341.41 |
10.480 |
| L&G Clean Water UCITS ETF |
03/08/2020 |
IE00BK5BC891 |
1500000 |
USD |
16428729.04 |
10.952 |
| L&G Artificial Intelligence UCITS ETF |
03/08/2020 |
IE00BK5BCD43 |
7946000 |
USD |
111036900.39 |
13.974 |
| L&G Healthcare Innovation UCITS ETF |
03/08/2020 |
IE00BK5BC677 |
3000000 |
USD |
42384054.52 |
14.128 |
| L&G Pharma Breakthrough UCITS ETF |
03/08/2020 |
IE00BF0H7608 |
2150000 |
USD |
26485148.30 |
12.319 |
| L&G Europe Equity (Responsible Exclusions) UCITS ETF |
03/08/2020 |
IE00BKLTRN76 |
9200000 |
EUR |
94330499.88 |
10.253 |
| L&G US Equity (Responsible Exclusions) UCITS ETF |
03/08/2020 |
IE00BKLWY790 |
57800000 |
USD |
650952133.09 |
11.262 |
| L&G Battery Value-Chain UCITS ETF |
03/08/2020 |
IE00BF0M2Z96 |
13200000 |
USD |
134027361.27 |
10.154 |
| L&G Ecommerce Logistics UCITS ETF |
03/08/2020 |
IE00BF0M6N54 |
9600000 |
USD |
110222926.58 |
11.482 |
| L&G ROBO Global Robotics and Automation UCITS ETF |
03/08/2020 |
IE00BMW3QX54 |
46830616 |
USD |
865980659.38 |
18.492 |
| L&G Cyber Security UCITS ETF |
03/08/2020 |
IE00BYPLS672 |
82611776 |
USD |
1711824057.37 |
20.721 |
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
END
NAVZZGGRZFNGGZZ
